Sachs Associates would like to say that we have enjoyed hosting you in-person and virtually and thank those who participated in our Sachs Spring Life Sciences Week, which incorporated the 5th Annual European HealthTech CEO Forum (Sachs_EHTF) and the 17th Annual European Life Sciences CEO Forum (Sachs_ELSF). A special thank you goes to the excellent line-up of sponsors, chairs, panellists, exhibitors and presenters who made such a broad and interesting programme possible and to those who participated in-person and during the virtual week.
The Life Sciences Week has proven to be successful in supporting our community with over 500 people from 30 countries registered and over 2000 in-person & online meetings completed.
To view the event photo gallery, please navigate to the 'PHOTOS’ tab. To watch a session on-demand, please navigate to the 'RECORDINGS' tab and select the panel or a session that you want to view. To view showcases, please click on the 'PRESENTERS' tab. Each company will have a showcase button, which will allow you to view their presentation. You can still message people and exchange contacts with people you did not have a chance to meet on the Online Meeting System. The events’ portal and meeting system will be available for review and messaging until the 27th of March 2024, 00:00 CET.
We are looking forward to welcoming you again in our future events!
SILVER SPONSOR:

BRONZE SPONSORS:


CONTRIBUTING SPONSOR:

Presenting Companies Included:
AATec Medical GmbH
AC BioScience SA
ActiTrexx GmbH
Adoram Therapeutics SA
AKIGAI
Akribion Genomics AG


Atamyo Therapeutics SAS
Bioxodes SA
Brainstorm Cell Therapeutics, Inc.






EvlaBio AG

FluoSphera SA
FoRx Therapeutics AG
Fusix Biotech GmbH
Hêmera srl

Innovent Biologics




Mabylon AG


MetrioPharm AG


PDC*line Pharma SA








TauC3 Biologics Limited
TME Pharma
TOLREMO Therapeutics AG

Vaccentis AG

Vidac Pharma Holding PLC
Exhibitors Included:

Confirmed Keynote Speakers Included:
CR
Chris Roberts
Head of EMEA Issuer Services, Hong Kong Exchanges and Clearing Limited
LC
Liesbeth Ceelen
CEO, BioLizard SA
MT
Matthias Tschöp
Chief Executive Officer & Chief Scientific Officer, Helmholtz Munich
Speakers and Chairs Included:
Andreas Wallnoefer
Managing Director, ClavystBio

Antoine Boulanger
Partner, Apollo Health Ventures
CT
Christian Thomsen
Global Head, CNS BD&L, Boehringer Ingelheim International GmbH

Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
Evonne Sepsis
Managing Director, ESC Advisors
FT
François Thomas
Operating Partner, Quadrille Capital
GF
Georgia Frost
Senior Associate, Dementia Discovery Fund 2 L.P. (SV Health Investors)
Helen Chen
Global Sector Co-Head, Healthcare & Life Sciences | Greater China Managing Partner, L.E.K. Consulting
KS
Katya Smirnyagina
Senior Partner, Oxford Science Enterprises

Michael Hübner
Director Early Innovation Partnering, Johnson & Johnson Innovation LLC
OZ
Olav Zilian
Medical Advisor, FluoSphera SA
Richard Ward
Executive Director, Oncology Search & Evaluation, GSK
Sarah Holland
CBO, CDR-Life AG
Stephanie Léouzon
Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
SM
Søren Møller
Managing Partner, Novo Holdings A/S

Victoria English
Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
AP
Alessandra Polara
Senior Director, Global BD, F. Hoffmann-La Roche AG
AP
Andreas Pahl
CEO, Heidelberg Pharma AG
AJ
Andreas Jurgeit
Partner, Gimv
AP
Anna Lisa Picciolo-Lehrke
Head Business Development Neurology, UCB Pharma
AM
Aram Mangasarian
CEO, TME Pharma
BA
Bauke Anninga
Investment Director, M Ventures
BT
Benjamin Thomas
Senior Vice President - Operations, Oxford BioTherapeutics Ltd.
BS
Birgit Steckel-Hamann
Sr. Director Diabetes External Innovation & Head of Public Private Partnerships Europe, Eli Lilly and Company
CR
Chris Roberts
Head of EMEA Issuer Services, Hong Kong Exchanges and Clearing Limited
CP
Christos Papadimitriou
Co-Founder & CEO, Tessara Therapeutics Pty Ltd.
DB
Dani Bach
Managing Partner, Limani Partners
DP
Daniel Parera
Partner, Kurma Partners
DC
David Colpman
Director, Alpina Life Science Advisors
DX
Donald Xu
Managing Partner, Lynx Financial Hong Kong Ltd.
DG
Dragan Grabulovski
Founder & CEO, Grabulovski Consulting Services GmbH
EC
Edouard Caram
Sr. Director, Global Partnership Rare Diseases & Neurosciences, Ipsen
EF
Emin Fadillioglu
CEO, Eczacibasi Pharmaceutical and Industrial Investment Co.
Eric Halioua
Executive Chairman, Ervimmune
FR
Francois Ravenelle
Founder & CEO, Inversago Pharma Inc.
GF
Göran Forsberg
CEO, Cantargia AB
JB
Jesus Baena
BD&L Transactions Oncology Director, Novartis AG
JT
Jonathan Tobin
Partner, Brandon Capital
Josua Jordi
Chief Scientific Officer, Tanai Therapeutics
Khatereh Ahmadi
Venture Partner, XGEN Venture SGR S.p.A.
KB
Klaus Breiner
Managing Partner, Pureos Bioventures
KD
Klaus Dugi
CEO, Vandria SA
Konstantin Petropoulos
CEO, Secarna Pharmaceuticals GmbH & Co. KG
LG
Lubor Gaal
CBO, MitoRx Therapeutics Limited
Lynn Durham
Founder & CEO, STALICLA SA
MD
Marc Ditmarsch
Chief Development Officer, NewAmsterdam Pharma
MR
Marc Robillard
CEO, Tagworks Pharmaceuticals BV
Maria Dahl
Executive Director, Business Development & Licensing, Novartis Pharma AG
ML
Marie Leblanc
Executive Director, Global Head of Account Management, Cell & Gene Technologies, Lonza AG
MR
Mark Rayner
Managing Partner, GOLDTRACK Ventures GmbH
Michael Altorfer
CEO, Swiss Biotech Association
Nigel Sheail
Partner, Versant Ventures
Paul Hermant
Partner, Bird & Bird (Belgium) LLP
PB
Peter Braun
CEO, TargImmune Therapeutics AG
Philip Larsen
CEO, SixPeaks Bio AG
RE
Rianne Ellenbroek
Principal, BioGeneration Ventures
Sarah Holland
CBO, CDR-Life AG
SC
Simon Chandler
CEO, Rinri Therapeutics Ltd.
SL
Stacy Lindborg
Co-CEO, Brainstorm Cell Therapeutics, Inc.
SP
Stefano Portolano
CEO, Azafaros Switzerland AG
Stephan Lensky
COO & CBO, EpimAb Biotherapeutics
SD
Stephen Doyle
Chief Business Officer, Aslan Pharmaceuticals
SH
Susan Hill
CEO, Mestag Therapeutics Ltd.
Tamas Schweighoffer
Co-Founding Partner, Forty51 Ventures AG
TS
Tom Shepherd
CEO, Captor Therapeutics S.A.
UW
Ulrich Wendt
Global Head Business Development Immunology & Inflammation, Sanofi